Caladrius Biosciences, Inc. (CLBS)

Oncology Corporate Profile

Stock Performance

4.2100
0.1300

HQ Location

420 Lexington Avenue, Suite 350
New York, NY 10170

Company Description

Caladrius Biosciences, Inc. (Caladrius, formerly NeoStem) is among the first of a new breed of immunotherapy companies with proven expertise and unique experience in cell process optimization, development, and manufacturing. Caladrius is a cell therapy leader with late-stage clinical programs based on a proprietary platform technology for immuno-oncology, as well as additional platform technologies for ischemic repair and immunomodulation, and capabilities that support other cell therapy developers. This integrated approach supports the industry in bringing significant life-improving medical treatments to market.

Website: http://www.caladrius.com/

This company does not have any commercial products

This company does not have any pipeline products

Source: http://www.caladrius.com/

Recent News Headlines

7/24/2017 06:18 pm

7/24/2017 06:18 pm

7/24/2017 06:18 pm

7/24/2017 06:18 pm

7/19/2017 06:18 am

7/19/2017 06:18 am

7/19/2017 06:18 am

7/12/2017 12:18 pm

7/12/2017 12:18 pm

7/12/2017 12:18 pm

7/9/2017 12:18 pm

7/2/2017 12:17 am

6/26/2017 06:17 am

6/26/2017 06:17 am

6/26/2017 06:17 am

6/14/2017 06:17 am

6/14/2017 06:17 am

6/1/2017 06:18 am

5/31/2017 06:17 am

5/24/2017 12:17 pm

5/23/2017 06:17 am

5/22/2017 06:17 am

5/18/2017 12:17 pm

5/1/2017 06:17 am

4/10/2017 06:17 pm